Weiwei Jin
Papers
2
Total Citations
52
H-Index
2
About
Dr. Weiwei Jin is a leading figure in the advancement of minimally invasive pancreatic surgery, with a primary focus on improving outcomes for patients with pancreatic and periampullary tumors. His most impactful work centers on the complex procedure of pancreatoduodenectomy, where he has been instrumental in rigorously evaluating the role of robotic and laparoscopic approaches against traditional open surgery. Dr. Jin’s major contribution is his leadership in the PORTAL trial, a landmark multicenter phase III non-inferiority randomized controlled trial (44 citations) that directly compares robotic to open pancreatoduodenectomy. This study protocol is critical for establishing evidence-based standards in a field where surgical innovation often outpaces rigorous validation. His earlier work, including a comprehensive review on the prospective of laparoscopic pancreatoduodenectomy for cancer management (8 citations), helped solidify the acceptance of minimally invasive techniques in pancreatic cancer surgery. By championing high-quality, prospective clinical trials, Dr. Jin is shaping the future of surgical oncology, ensuring that technological advancements translate into tangible benefits for patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2